Loading…
Disclosed for 71 months, Nov 2020 to Sep 2026.
quant ESG Integration Strategy Fund is an active equity fund in the Sectoral / Thematic category from quant Mutual Fund. In December 2020 it disclosed 20 stocks worth ₹12.9 Cr, down ₹54 L from Nov 2020. Its largest positions were Fortis Healthcare Limited (8.8%), HCL Technologies Limited (8.3%), Tata Elxsi Limited (7.2%); the ten largest together made up 69.8% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 32.0% of its equity. Cash and debt stood at 1.8%. Compared with Nov 2020 the fund entered 10 new stocks and exited 12.
Top-10 weight is higher than 93% of peers
Holds more stocks than 5% of peers
Holds more cash than 28% of peers
What these mean: concentration · cash
Every line the fund disclosed, with the change against Nov 2020. Click a column to sort; click a company to see every fund that owns it. New to these? How to read a portfolio.
| Fortis Healthcare Limited | 8.76% | down 0.20 pts | ₹1.1 Cr | down ₹7 L | Trimmed |
| HCL Technologies Limited | 8.27% | up 8.27 pts | ₹1.1 Cr | up ₹1.1 Cr | New |
| Tata Elxsi Limited | 7.24% | up 7.24 pts | ₹94 L | up ₹94 L | New |
| Adani Ports and Special Economic Zone Limited | 7.14% | up 0.13 pts | ₹92 L | down ₹2 L | Trimmed |
| Sun Pharmaceutical Industries Limited | 6.87% | up 4.02 pts | ₹89 L | up ₹50 L | Added |
| Infosys Limited | 6.70% | up 6.70 pts | ₹87 L | up ₹87 L | New |
| Divi's Laboratories Limited | 6.56% | up 6.56 pts | ₹85 L | up ₹85 L | New |
| Tech Mahindra Limited | 6.24% | up 6.24 pts | ₹81 L | up ₹81 L | New |
| Bharti Airtel Limited | 6.11% | up 6.11 pts | ₹79 L | up ₹79 L | New |
| Alembic Pharmaceuticals Limited | 5.93% | up 4.52 pts | ₹77 L | up ₹58 L | Added |
| Dabur India Limited | 5.78% | up 2.00 pts | ₹75 L | up ₹24 L | Added |
| Biocon Limited | 4.32% | up 4.32 pts | ₹56 L | up ₹56 L | New |
| India Limited | 3.84% | down 0.18 pts | ₹50 L | down ₹5 L | Trimmed |
| Fermenta Biotech Limited | 3.60% | up 0.32 pts | ₹47 L | up ₹2 L | Added |
| Dr. Reddy's Laboratories Limited | 3.02% | up 3.02 pts | ₹39 L | up ₹39 L | New |
| ICICI Lombard General Insurance Company Limited | 2.70% | up 0.23 pts | ₹35 L | up ₹2 L | Added |
| Jash Engineering Limited | 1.88% | up 0.13 pts | ₹24 L | up ₹1 L | Added |
| Cash, TREPS & receivables | 1.84% | down 5.80 pts | ₹24 L | down ₹79 L | Trimmed |
| Zydus Wellness Limited | 1.54% | up 0.16 pts | ₹20 L | up ₹1 L | Added |
| Jubilant Pharmova Limited | 1.14% | up 1.14 pts | ₹15 L | up ₹15 L | New |
| Hindustan Unilever Limited | 0.53% | up 0.53 pts | ₹7 L | up ₹7 L | New |
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Compared with
Since Nov 2020, the weight rose most in IT - Software (+29.0 pts) and Pharmaceuticals & Biotechnology (+19.0 pts), and fell most in Power (−8.3 pts) and Realty (−8.3 pts).
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
| Sector | Nov 2020 | Dec 2020 |
|---|---|---|
| Pharmaceuticals & Biotechnology | 13.0% | 32.0% |
| IT - Software | — | 29.0% |
| Healthcare Services | 9.7% | 8.9% |
| Transport Infrastructure | 7.6% | 7.3% |
| Telecom - Services | — | 6.2% |
| Personal Products | 4.1% | 5.9% |
| Power | 12.2% | 3.9% |
| Insurance | 2.7% | 2.8% |
| Industrial Manufacturing | 1.9% | 1.9% |
| Food Products | 1.5% | 1.6% |
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal. More on reading cash.
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.
| 2 |
| −2.0% |
| 4.7% |
| 7% |
| May 2026 | ₹294 Cr | 12 | 2 | 4 | −4.9% | 1.2% | 6% |
| Apr 2026 | ₹264 Cr | 14 | 3 | 5 | 0.6% | 6.7% | 6% |
| Mar 2026 | ₹226 Cr | 16 | 3 | 2 | −5.9% | 1.2% | 6% |
| Feb 2026 | ₹257 Cr | 15 | 5 | 2 | 0.8% | 6.6% | 6% |
| Jan 2026 | ₹252 Cr | 12 | 4 | 6 | −4.0% | 0.3% | 5% |
| Dec 2025 | ₹269 Cr | 14 | 4 | 7 | −5.1% | 0.4% | 5% |
| Nov 2025 | ₹273 Cr | 17 | 5 | 5 | 4.6% | 9.8% | 439% |
| Oct 2025 | ₹274 Cr | 17 | 5 | 5 | 5.3% | 9.7% | 386% |
| Sep 2025 | ₹277 Cr | 17 | 1 | 2 | −0.7% | 2.2% | 324% |
| Aug 2025 | ₹273 Cr | 18 | 3 | 2 | −4.6% | 0.2% | 327% |
| Jul 2025 | ₹285 Cr | 17 | 4 | 2 | −4.1% | 1.4% | 342% |
| Jun 2025 | ₹305 Cr | 15 | 2 | 0 | −4.1% | 0.4% | 357% |
| May 2025 | ₹299 Cr | 13 | 4 | 6 | −2.8% | 0.8% | 385% |
| Apr 2025 | ₹284 Cr | 15 | 2 | 6 | −1.9% | 0.8% | 392% |
| Mar 2025 | ₹277 Cr | 19 | 1 | 2 | −1.6% | 0.5% | 432% |
| Feb 2025 | ₹260 Cr | 20 | 8 | 4 | 0.7% | 0.7% | 439% |
| Jan 2025 | ₹288 Cr | 16 | 3 | 3 | 0.5% | 0.5% | 451% |
| Dec 2024 | ₹298 Cr | 16 | 1 | 5 | 3.3% | 3.3% | 470% |
| Nov 2024 | ₹312 Cr | 20 | 3 | 1 | 0.9% | 0.9% | 5% |
| Oct 2024 | ₹309 Cr | 18 | 4 | 1 | 1.6% | 1.6% | 5% |
For any of the 47 earlier months, choose it in “Portfolio as of” at the top of the page.